These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 8223141

  • 1. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A, Giovannini L, Galmozzi G, Bertelli AA.
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [Abstract] [Full Text] [Related]

  • 2. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine.
    Bertelli A, Bertelli AA, Galmozzi G, Giovannini L, Mian M.
    Drugs Exp Clin Res; 1993; 19(2):75-8. PubMed ID: 8223146
    [Abstract] [Full Text] [Related]

  • 3. The potentiating effect of propionyl carnitine on prostacycline prevention of thrombosis induced by endothelin (ET-1) and K-carrageenin.
    Bertelli A, Bertelli AA, Giovannini L.
    Drugs Exp Clin Res; 1994; 20(1):7-11. PubMed ID: 7924894
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of histamine release and pressure increase induced by endothelin (ET-1) in isolated rat kidneys treated with propionyl carnitine.
    Bertelli A, Giovannini L, Bertelli AA.
    Drugs Exp Clin Res; 1992; 18(8):349-53. PubMed ID: 1284047
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect.
    Longoni B, Giovannini L, Migliori M, Bertelli AA, Bertelli A.
    Int J Tissue React; 1999; 21(1):7-11. PubMed ID: 10463135
    [Abstract] [Full Text] [Related]

  • 6. L-propionyl carnitine reduces toxicity correlated to cyclosporine-induced intracellular ATP concentrations.
    Giovannini L, Migliori M, De Pietro S, Taccola D, Panichi V, Bertelli AA, Bertelli A.
    Drugs Exp Clin Res; 1999; 25(4):173-7. PubMed ID: 10442274
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of propionyl-L-carnitine on plasma extravasation induced by irritants in rodents.
    Amico-Roxas M, Caruso A, Cutuli VM, de Bernardis E, Leonardi G.
    Drugs Exp Clin Res; 1993; 19(5):213-7. PubMed ID: 8174493
    [Abstract] [Full Text] [Related]

  • 8. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H, Hirschelmann R, Giessler AJ.
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [Abstract] [Full Text] [Related]

  • 9. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM, Al-Majed AA, Al-Yahya AA, Al-Rejaie SS, Bakheet SA, Al-Shabanah OA, Sayed-Ahmed MM.
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [Abstract] [Full Text] [Related]

  • 10. Anaplerotic effect of propionyl carnitine in rat heart mitochondria.
    Tassani V, Cattapan F, Magnanimi L, Peschechera A.
    Biochem Biophys Res Commun; 1994 Mar 15; 199(2):949-53. PubMed ID: 8135845
    [Abstract] [Full Text] [Related]

  • 11. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products.
    Bueno R, Alvarez de Sotomayor M, Perez-Guerrero C, Gomez-Amores L, Vazquez CM, Herrera MD.
    Life Sci; 2005 Sep 09; 77(17):2082-97. PubMed ID: 15958269
    [Abstract] [Full Text] [Related]

  • 12. Role of endothelin-1 in carrageenin-induced inflammation.
    Bertelli A, Clerico A, Chicca A, Giovannini L, Gorio A, Romano MA.
    Int J Tissue React; 1992 Sep 09; 14(5):225-30. PubMed ID: 1300308
    [Abstract] [Full Text] [Related]

  • 13. Short term effects of intra-arterial propionyl-L-carnitine on isolated canine hind-limbs.
    Cevese A, Schena F, Poltronieri R, Cerutti G.
    Cardioscience; 1995 Mar 09; 6(1):59-64. PubMed ID: 7605897
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C.
    Ann N Y Acad Sci; 2004 Nov 09; 1033():79-91. PubMed ID: 15591005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective action of propionyl-L-carnitine on toxicity induced by hyperbaric oxygen.
    Bertelli A, Giovannini L, Mian M, Spaggiari PG.
    Drugs Exp Clin Res; 1990 Nov 09; 16(10):527-30. PubMed ID: 2100735
    [Abstract] [Full Text] [Related]

  • 17. Rheological activity of propionyl L-carnitine.
    Pola P, Flore R, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1991 Nov 09; 17(3):191-6. PubMed ID: 1914846
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A, Cutuli VM, De Bernardis E, Leonardi G, Amico-Roxas M.
    Pharmacol Res; 1995 Jan 09; 31(1):67-72. PubMed ID: 7784308
    [Abstract] [Full Text] [Related]

  • 19. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
    Mingorance C, Gonzalez del Pozo M, Dolores Herrera M, Alvarez de Sotomayor M.
    Br J Nutr; 2009 Oct 09; 102(8):1145-53. PubMed ID: 19545458
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats.
    Gómez-Amores L, Mate A, Revilla E, Santa-María C, Vázquez CM.
    Life Sci; 2006 Mar 20; 78(17):1945-52. PubMed ID: 16263137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.